Introduction
Sevoran Solution for Inhalation 250 mg/250 ml is a volatile anesthetic used for induction and maintenance of general anesthesia during surgical procedures. It is known for its rapid onset and recovery properties, making it a popular choice in both adult and pediatric anesthesia. Sevoran Solution for Inhalation 250 mg/250 ml is administered via inhalation and is used in conjunction with other anesthetic agents to provide balanced anesthesia.
Uses
Sevoran Solution for Inhalation 250 mg/250 ml is used for:
- Induction and maintenance of general anesthesia during surgical and diagnostic procedures.
- Anesthesia for both adults and pediatric patients due to its rapid onset and minimal irritation to the respiratory tract.
- Short and long surgical procedures where rapid emergence from anesthesia is desired.
| Brand Name | Sevoran |
|---|---|
| Type | Solution for Inhalation |
| Weight | 250 mg/250 ml |
| Generic | Sevoflurane |
| Manufacturer | Techno Drugs Ltd. |
| Available in | English বাংলা |
Mechanism of Action
Sevoran Solution for Inhalation 250 mg/250 ml acts by enhancing the inhibitory neurotransmission in the central nervous system. It interacts with gamma-aminobutyric acid (GABA) receptors and modulates ion channels to decrease neuronal excitability. This results in a loss of consciousness, analgesia, and muscle relaxation. The exact molecular mechanisms are not fully understood but involve a complex interaction with various neurotransmitter systems.
How Long Does It Take to Work?
Sevoran Solution for Inhalation 250 mg/250 ml has a rapid onset of action, typically taking 1 to 2 minutes to achieve adequate anesthesia after initiation of inhalation. The time to reach desired anesthetic depth depends on the concentration used and the patient's individual response. Recovery from sevoflurane anesthesia is also relatively quick, with most patients regaining consciousness within minutes after discontinuation.
Absorption
Sevoran Solution for Inhalation 250 mg/250 ml is absorbed through the lungs when inhaled. It rapidly enters the bloodstream and is distributed throughout body tissues. The drug's high potency and low solubility in blood allow for efficient absorption and quick onset of anesthesia.
Route of Elimination
Sevoran Solution for Inhalation 250 mg/250 ml is primarily eliminated through the lungs. About 2% to 5% of the administered dose is metabolized by the liver, with the majority of the drug being exhaled unchanged. The rapid elimination through the lungs contributes to the quick recovery from anesthesia.
Dosage
Route of administration: It should be administered by inhalation delivered from a vaporizer. The concentration of Sevoflurane being delivered from a vaporizer should be known. This may be accomplished by using a vaporizer calibrated specifically for Sevoflurane. Sevoflurane should be administered only by persons trained in the administration of general anesthesia. Facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment and circulatory resuscitation must be immediately available. Since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of Sevoflurane should be used. The administration of general anesthesia must be individualized based on the patient's response.Pre-anesthetic medication: No specific premedication is either indicated or contraindicated with Sevoflurane. The decision as to whether or not to premedicate and the choice of premedication is left to the discretion of the anesthesiologist.
Induction: Sevoflurane has a nonpungent odor and does not cause respiratory irritability; it is suitable for mask induction in pediatrics and adults.
Maintenance: Surgical levels of anesthesia can usually be achieved with concentrations of 0.5-3% Sevoflurane with or without the concomitant use of nitrous oxide. Sevoflurane can be administered with any type of anesthesia circuit.
Use in children and adolescents: The safety and efficacy of induction and maintenance of general anesthesia with sevoflurane have been established in pediatric patients aged 1 to 18 years
The dosage of sevoflurane is individualized based on the patient's age, weight, and the type of surgical procedure. Typical concentrations used are:
- For induction: 1.5% to 5% inhaled sevoflurane in a mixture with oxygen or air.
- For maintenance: 0.5% to 2.5% inhaled sevoflurane, adjusted based on the depth of anesthesia required.
Administration
Sevoran Solution for Inhalation 250 mg/250 ml is administered using a calibrated vaporizer connected to an anesthesia machine. It is delivered through a face mask or endotracheal tube in a mixture with oxygen or nitrous oxide. The concentration of sevoflurane is adjusted throughout the procedure based on the patient's response and the surgical requirements.
Side Effects
Common side effects of sevoflurane include:
- Nausea and vomiting
- Respiratory depression
- Hypotension
- Headache
- Malignant hyperthermia (a rare but severe reaction to anesthetics)
- Renal impairment due to metabolism of sevoflurane into fluoride ions
- Delayed emergence from anesthesia
Toxicity
Sevoran Solution for Inhalation 250 mg/250 ml toxicity can manifest as excessive respiratory depression, cardiovascular effects such as hypotension, and metabolic disturbances. In rare cases, it may cause malignant hyperthermia, a life-threatening condition requiring immediate intervention. Monitoring and appropriate dosing are crucial to minimize the risk of toxicity.
Precautions
Precautions include:
- Monitoring for respiratory and cardiovascular function throughout the procedure.
- Assessing for a history of malignant hyperthermia or other contraindications.
- Ensuring proper ventilation and oxygenation during and after administration.
Interaction
Sevoran Solution for Inhalation 250 mg/250 ml may interact with other anesthetic agents and medications that affect cardiovascular and respiratory function. Caution should be exercised when used with other CNS depressants or drugs that may affect blood pressure or heart function.
Disease Interaction
Sevoran Solution for Inhalation 250 mg/250 ml should be used with caution in patients with:
- Pre-existing respiratory or cardiovascular conditions.
- Renal impairment, due to potential accumulation of fluoride metabolites.
- History of malignant hyperthermia or susceptibility to such reactions.
Drug Interaction
Drug interactions may occur with:
- Other anesthetics or sedatives, which may require dosage adjustments.
- Drugs that affect liver or renal function, potentially impacting sevoflurane metabolism.
Food Interactions
There are no significant food interactions with sevoflurane. It is administered as part of a controlled anesthesia regimen and is not affected by oral intake.
Pregnancy Use
Sevoran Solution for Inhalation 250 mg/250 ml is classified as a Category B drug during pregnancy. Animal studies have not shown any harm, but there are limited studies in pregnant women. It should be used during pregnancy only if the potential benefits outweigh the risks. The drug should be used cautiously and only when necessary.
Lactation Use
Sevoran Solution for Inhalation 250 mg/250 ml is not known to be excreted in breast milk. However, as a precaution, it is recommended to avoid breastfeeding for 24 hours after administration. Consultation with a healthcare provider is advised for appropriate timing and alternatives.
Acute Overdose
Acute overdose of sevoflurane can lead to excessive respiratory depression, cardiovascular instability, and prolonged recovery. Treatment involves discontinuation of the anesthetic, supportive care, and monitoring. Immediate intervention may be required if severe symptoms occur.
Contraindication
Sevoran Solution for Inhalation 250 mg/250 ml is contraindicated in patients with:
- Known or suspected malignant hyperthermia.
- Severe hepatic dysfunction.
- History of hypersensitivity to sevoflurane or other volatile anesthetics.
Use Direction
Sevoran Solution for Inhalation 250 mg/250 ml should be administered by a trained anesthesiologist or healthcare professional using appropriate equipment for inhalational anesthesia. The concentration and flow rates are adjusted based on the patient’s needs and the surgical procedure.
Storage Conditions
Store sevoflurane at room temperature, away from heat and direct light. The drug should be kept in its original container and properly sealed to maintain stability. Ensure it is out of reach of children.
Volume of Distribution
The volume of distribution for sevoflurane is approximately 2 to 3 L/kg, reflecting its extensive distribution in body tissues, particularly in the brain and fatty tissues where it accumulates.
Half Life
The elimination half-life of sevoflurane is approximately 1 to 2 hours. This relatively short half-life contributes to its rapid recovery profile, with most patients regaining consciousness quickly after discontinuation.
Clearance
Sevoran Solution for Inhalation 250 mg/250 ml is primarily cleared from the body through the lungs. Its clearance rate is influenced by ventilation and the rate of exhalation. The drug's low blood solubility allows for efficient elimination and quick recovery.
See in details version Sevoran Solution for Inhalation 250 mg/250 ml also Sevoran Solution for Inhalation 250 mg/250 ml in bangla
